Antigen-specific drug-targeting used to manipulate an immune response in vivo.
about
Selective elimination of idiotype-binding cells in vivo by a drug-idiotype conjugate demonstrates the functional significance of these cells in immune regulationXenogeneic monoclonal antibodies in the management of cancer: control of their in vivo immunogenicity and induction of specific unresponsiveness using an antibody-drug immunoconjugate.
P2860
Antigen-specific drug-targeting used to manipulate an immune response in vivo.
description
1987 nî lūn-bûn
@nan
1987 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Antigen-specific drug-targeting used to manipulate an immune response in vivo.
@ast
Antigen-specific drug-targeting used to manipulate an immune response in vivo.
@en
Antigen-specific drug-targeting used to manipulate an immune response in vivo.
@nl
type
label
Antigen-specific drug-targeting used to manipulate an immune response in vivo.
@ast
Antigen-specific drug-targeting used to manipulate an immune response in vivo.
@en
Antigen-specific drug-targeting used to manipulate an immune response in vivo.
@nl
prefLabel
Antigen-specific drug-targeting used to manipulate an immune response in vivo.
@ast
Antigen-specific drug-targeting used to manipulate an immune response in vivo.
@en
Antigen-specific drug-targeting used to manipulate an immune response in vivo.
@nl
P2093
P2860
P356
P1476
Antigen-specific drug-targeting used to manipulate an immune response in vivo.
@en
P2093
G L Mayers
M M Abu-hadid
R B Bankert
P2860
P304
P356
10.1073/PNAS.84.20.7232
P407
P577
1987-10-01T00:00:00Z